Skip to main content
. 2010 Mar 12;21(2):91–98. doi: 10.1016/j.cytogfr.2010.02.006

Fig. 5.

Fig. 5

Clinical trial design for the randomised phase III trial of carboplatin, paclitaxel and reovirus or placebo in patients with relapsed/metastatic, platin-refractory head and neck cancer (SCCHN, squamous cell cancer of the head and neck; AUC, area under the curve; CR, complete response; PR, partial response; SD, stable disease).